Fresh Tracks Therapeutics Inc (NASDAQ:FRTX)

Delayed Data
As of May 31
 -0.0495 / -8.39%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Fresh Tracks Therapeutics Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +2,120.17% increase from the last price of 0.54.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Fresh Tracks Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -47.37%
Growthannually 27.16%


Growthquarterly 5,455.56%
Growthannually -13.58%
Key to the earnings and sales forecast charts.